|
FY2025
12 months to Jan 2, 2026
|
FY2024
12 months to Dec 27, 2024
|
FY2023
12 months to Dec 29, 2023
|
FY2022
12 months to Dec 30, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Other non-cash items | |||||
| Deferred income taxes, net | |||||
| (Gain) loss on sale/disposal of equipment | |||||
| Provision for doubtful accounts | |||||
| Stock-based compensation | |||||
| Accretion and fair value adjustments of contingent consideration | |||||
| Changes in operating assets and liabilities, net of effects from business acquisitions: | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Other receivables | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Contract liabilities | |||||
| Right-of-use assets | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of equipment, software, and leasehold improvements | |||||
| Proceeds from sale of equipment | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Payments on contingent consideration | |||||
| Payment on restricted cash | |||||
| Payments on notes payable | |||||
| Payments on debt issuance costs | |||||
| Borrowings under term loan facility and line of credit | |||||
| Borrowings under prior term loan and line of credit | |||||
| Payments made to retire prior credit agreement | |||||
| Borrowing to fund new credit agreement | |||||
| Principal payments on outstanding debt | |||||
| Principal payments on finance leases | |||||
| Proceeds from stock option exercise | |||||
| Proceeds from sales of common stock under employee stock purchase plan | |||||
| Cash used to pay taxes on stock grants | |||||
| Net cash (used in) provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Cash paid (received) during the period for: | |||||
| Interest | |||||
| Income taxes | |||||
| Supplemental disclosures of noncash investing and financing activities: | |||||
| (Gain) loss on cash flow hedge valuations, net of tax | |||||
| Issuance of common stock related to business acquisitions | |||||
| Contingent consideration related to business acquisitions | |||||
| Equipment acquired under finance leases | |||||
Loading...